Literature DB >> 10334372

Access to narcotic addiction treatment and medical care: prospects for the expansion of methadone maintenance treatment.

D C Lewis1.   

Abstract

Methadone maintenance treatment (MMT) for opioid addiction is safe and effective but underutilized because of inaccessibility, under-financing and the stigma generally attached to maintenance therapies. In addition, cumbersome regulation of methadone prescription and treatment impedes the delivery of care and retards expansion of methadone maintenance into office practice settings. Exaggeration of the problem of methadone diversion further hinders development of MMT. Despite obstacles, methadone maintenance has been successfully expanded and extended into primary care settings abroad. Initial trials in the U.S. have shown that methadone maintenance in physician office-based settings yields positive results with some advantages over care in large methadone clinics. Alternatives to methadone, such as buprenorphine, are also being explored in primary care settings. With implementation of the NIH Consensus Statement on Effective Medical Treatment of Heroin Addiction, including training of primary care physicians, methadone maintenance treatment could reach many more patients, achieve higher success rates, and substantially reduce the deleterious effects of opioid addiction in the U.S.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10334372     DOI: 10.1300/J069v18n02_02

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  10 in total

1.  Access to publicly funded methadone maintenance treatment in two western states.

Authors:  Dennis Deck; Matthew J Carlson
Journal:  J Behav Health Serv Res       Date:  2004 Apr-Jun       Impact factor: 1.505

2.  Why don't out-of-treatment individuals enter methadone treatment programmes?

Authors:  James A Peterson; Robert P Schwartz; Shannon Gwin Mitchell; Heather Schacht Reisinger; Sharon M Kelly; Kevin E O'Grady; Barry S Brown; Michael H Agar
Journal:  Int J Drug Policy       Date:  2008-09-20

3.  Patterns in admission delays to outpatient methadone treatment in the United States.

Authors:  Jan Gryczynski; Robert P Schwartz; David S Salkever; Shannon Gwin Mitchell; Jerome H Jaffe
Journal:  J Subst Abuse Treat       Date:  2011-08-06

4.  Heroin Use, HIV-Risk, and Criminal Behavior in Baltimore: Findings from Clinical Research.

Authors:  Robert P Schwartz; Sharon M Kelly; Jan Gryczynski; Shannon Gwin Mitchell; Kevin E O'Grady; Jerome H Jaffe
Journal:  J Addict Dis       Date:  2015

5.  The Supply of Physicians Waivered to Prescribe Buprenorphine for Opioid Use Disorders in the United States: A State-Level Analysis.

Authors:  Hannah K Knudsen
Journal:  J Stud Alcohol Drugs       Date:  2015-07       Impact factor: 2.582

6.  Mutual mistrust in the medical care of drug users: the keys to the "narc" cabinet.

Authors:  Joseph O Merrill; Lorna A Rhodes; Richard A Deyo; G Alan Marlatt; Katharine A Bradley
Journal:  J Gen Intern Med       Date:  2002-05       Impact factor: 5.128

7.  Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland.

Authors:  Shannon Gwin Mitchell; Sharon M Kelly; Barry S Brown; Heather Schacht Reisinger; James A Peterson; Adrienne Ruhf; Michael H Agar; Kevin E O'Grady; Robert P Schwartz
Journal:  Am J Addict       Date:  2009 Sep-Oct

8.  Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013.

Authors:  Rachel M Burns; Rosalie L Pacula; Sebastian Bauhoff; Adam J Gordon; Hollie Hendrikson; Douglas L Leslie; Bradley D Stein
Journal:  Subst Abus       Date:  2015-11-13       Impact factor: 3.716

9.  Scaling-up interim methadone maintenance: treatment for 1,000 heroin-addicted individuals.

Authors:  Robert P Schwartz; Jerome H Jaffe; Kevin E O'Grady; Babita Das; David A Highfield; Monique E Wilson
Journal:  J Subst Abuse Treat       Date:  2009-06-21

Review 10.  Reducing Fatal Opioid Overdose: Prevention, Treatment and Harm Reduction Strategies.

Authors:  Kathryn F Hawk; Federico E Vaca; Gail D'Onofrio
Journal:  Yale J Biol Med       Date:  2015-09-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.